Biallelic truncating variants in the muscular A-type lamin-interacting protein (MLIP) gene cause myopathy with hyperCKemia.
MLIP
creatine kinase
lamin
muscular A-type lamin-interacting protein
myopathy
Journal
European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311
Informations de publication
Date de publication:
04 2022
04 2022
Historique:
revised:
02
12
2021
received:
04
09
2021
accepted:
10
12
2021
pubmed:
23
12
2021
medline:
5
4
2022
entrez:
22
12
2021
Statut:
ppublish
Résumé
Muscular A-type lamin-interacting protein (MLIP) is most abundantly expressed in cardiac and skeletal muscle. In vitro and animal studies have shown its regulatory role in myoblast differentiation and in organization of myonuclear positioning in skeletal muscle, as well as in cardiomyocyte adaptation and cardiomyopathy. We report the association of biallelic truncating variation in the MLIP gene with human disease in five individuals from two unrelated pedigrees. Clinical evaluation and exome sequencing were performed in two unrelated families with elevated creatine kinase level. Family 1. A 6-year-old girl born to consanguineous parents of Arab-Muslim origin presented with myalgia, early fatigue after mild-to-moderate physical exertion, and elevated creatine kinase levels up to 16,000 U/L. Exome sequencing revealed a novel homozygous nonsense variant, c.2530C>T; p.Arg844Ter, in the MLIP gene. Family 2. Three individuals from two distantly related families of Old Order Amish ancestry presented with elevated creatine kinase levels, one of whom also presented with abnormal electrocardiography results. On exome sequencing, all showed homozygosity for a novel nonsense MLIP variant c.1825A>T; p.Lys609Ter. Another individual from this pedigree, who had sinus arrhythmia and for whom creatine kinase level was not available, was also homozygous for this variant. Our findings suggest that biallelic truncating variants in MLIP result in myopathy characterized by hyperCKemia. Moreover, these cases of MLIP-related disease may indicate that at least in some instances this condition is associated with muscle decompensation and fatigability during low-to-moderate intensity muscle exertion as well as possible cardiac involvement.
Sections du résumé
BACKGROUND AND PURPOSE
Muscular A-type lamin-interacting protein (MLIP) is most abundantly expressed in cardiac and skeletal muscle. In vitro and animal studies have shown its regulatory role in myoblast differentiation and in organization of myonuclear positioning in skeletal muscle, as well as in cardiomyocyte adaptation and cardiomyopathy. We report the association of biallelic truncating variation in the MLIP gene with human disease in five individuals from two unrelated pedigrees.
METHODS
Clinical evaluation and exome sequencing were performed in two unrelated families with elevated creatine kinase level.
RESULTS
Family 1. A 6-year-old girl born to consanguineous parents of Arab-Muslim origin presented with myalgia, early fatigue after mild-to-moderate physical exertion, and elevated creatine kinase levels up to 16,000 U/L. Exome sequencing revealed a novel homozygous nonsense variant, c.2530C>T; p.Arg844Ter, in the MLIP gene. Family 2. Three individuals from two distantly related families of Old Order Amish ancestry presented with elevated creatine kinase levels, one of whom also presented with abnormal electrocardiography results. On exome sequencing, all showed homozygosity for a novel nonsense MLIP variant c.1825A>T; p.Lys609Ter. Another individual from this pedigree, who had sinus arrhythmia and for whom creatine kinase level was not available, was also homozygous for this variant.
CONCLUSIONS
Our findings suggest that biallelic truncating variants in MLIP result in myopathy characterized by hyperCKemia. Moreover, these cases of MLIP-related disease may indicate that at least in some instances this condition is associated with muscle decompensation and fatigability during low-to-moderate intensity muscle exertion as well as possible cardiac involvement.
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1174-1180Informations de copyright
© 2021 European Academy of Neurology.
Références
Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology. 2000;54(6):1373-1376. doi:10.1212/wnl.54.6.1373
Papadopoulos C, LaforÊt P, Nectoux J, et al. Hyperckemia and myalgia are common presentations of anoctamin-5-related myopathy in French patients. Muscle Nerve. 2017;56(6):1096-1100. doi:10.1002/mus.25608
Nakamura A, Fueki N, Shiba N, et al. Deletion of exons 3-9 encompassing a mutational hot spot in the DMD gene presents an asymptomatic phenotype, indicating a target region for multiexon skipping therapy. J Hum Genet. 2016;61(7):663-667. doi:10.1038/jhg.2016.28
Taglia A, Petillo R, D'Ambrosio P, et al. Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene. Acta Myol. 2015;34(1):9-13.
Okahashi S, Ogawa G, Suzuki M, Ogata K, Nishino I, Kawai M. Asymptomatic sporadic dysferlinopathy presenting with elevation of serum creatine kinase. Typical distribution of muscle involvementshown by MRI but not by CT. Intern Med. 2008;47(4):305-307. doi:10.2169/internalmedicine.47.0519
Rubegni A, Malandrini A, Dosi C, et al. Next-generation sequencing approach to hyperCKemia: a 2-year cohort study. Neurol Genet. 2019;5(5):e352. doi:10.1212/NXG.0000000000000352
Lopes Abath Neto O, Medne L, Donkervoort S, et al. MLIP causes recessive myopathy with rhabdomyolysis, myalgia and baseline elevated serum creatine kinase. Brain. 2021;144(9):2722-2731. doi:10.1093/brain/awab275
Huang ZP, Seok HY, Zhou B, et al. CIP, a cardiac Isl1-interacting protein, represses cardiomyocyte hypertrophy. Circ Res. 2012;110(6):818-830. doi:10.1161/CIRCRESAHA.111.259663
Huang ZP, Kataoka M, Chen J, et al. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis. J Clin Invest. 2015;125(11):4122-4134. doi:10.1172/JCI82423
Cattin ME, Wang J, Weldrick JJ, et al. Deletion of MLIP (muscle-enriched A-type lamin-interacting protein) leads to cardiac hyperactivation of Akt/mammalian target of rapamycin (mTOR) and impaired cardiac adaptation. J Biol Chem. 2015;290(44):26699-26714. doi:10.1074/jbc.M115.678433
Ahmady E, Deeke SA, Rabaa S, et al. Identification of a novel muscle A-type lamin-interacting protein (MLIP). J Biol Chem. 2011;286(22):19702-19713. doi:10.1074/jbc.M110.165548
Cattin ME, Deeke SA, Dick SA, et al. Expression of murine muscle-enriched A-type lamin-interacting protein (MLIP) is regulated by tissue-specific alternative transcription start sites. J Biol Chem. 2018;293(51):19761-19770. doi:10.1074/jbc.RA118.003758
Ho R, Hegele RA. Complex effects of laminopathy mutations on nuclear structure and function. Clin Genet. 2019;95(2):199-209. doi:10.1111/cge.13455
Ahmady E, Blais A, Burgon PG. Muscle enriched lamin interacting protein (Mlip) binds chromatin and is required for myoblast differentiation. Cells. 2021;10(3):615. doi:10.3390/cells10030615
Liu J, Huang ZP, Nie M, et al. Regulation of myonuclear positioning and muscle function by the skeletal muscle-specific CIP protein. Proc Natl Acad Sci USA. 2020;117(32):19254-19265. doi:10.1073/pnas.1922911117
Esslinger U, Garnier S, Korniat A, et al. Exome-wide association study reveals novel susceptibility genes to sporadic dilated cardiomyopathy. PLoS One. 2017;12(3):e0172995. doi:10.1371/journal.pone.0172995
Gruenbaum Y, Foisner R. Lamins: nuclear intermediate filament proteins with fundamental functions in nuclear mechanics and genome regulation. Annu Rev Biochem. 2015;84:131-164. doi:10.1146/annurev-biochem-060614-034115